Clinical value of the expression levels of protein tyrosine phosphatase non-receptor type 22.6 mRNA in peripheral blood mononuclear cells in Crohn’s disease
Author(s) -
Mei Hu,
Zhitao Chen,
Yusheng Liao,
Jie Wu,
Dan Zheng,
Heng Zhang
Publication year - 2022
Publication title -
clinical and experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1093/cei/uxac061
Subject(s) - peripheral blood mononuclear cell , ptpn22 , protein tyrosine phosphatase , medicine , immunology , clinical significance , endocrinology , messenger rna , phosphatase , receptor , biology , enzyme , genotype , gene , in vitro , biochemistry , single nucleotide polymorphism
To explore the relationship between the expression levels of protein tyrosine phosphatase non-receptor type (PTPN) 22.6 mRNA in peripheral blood mononuclear cells (PBMCs) and the disease activity as well as clinical characteristics in Crohn's disease (CD) patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom